Deborah Geraghty
Chief Executive Officer at Anokion SA
Profile
Deborah Geraghty is currently the President & Chief Executive Officer at Anokion SA. She is also a Director at ReAlta Life Sciences, Inc. and a Trustee at Emma Willard School, Inc. Previously, she held the position of Senior Vice President & Head-Corporate Strategy at Dimension Therapeutics, Inc. Dr. Geraghty completed her undergraduate degree at Union College (New York), her doctorate at the University of Vermont, and her MBA at The Carroll School.
Deborah Geraghty active positions
| Companies | Position | Start |
|---|---|---|
| Emma Willard School, Inc. | Director/Board Member | - |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Chief Executive Officer | 2021-02-22 |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Director/Board Member | - |
Former positions of Deborah Geraghty
| Companies | Position | End |
|---|---|---|
| DIMENSION THERAPEUTICS INC | Corporate Officer/Principal | 2017-11-30 |
Training of Deborah Geraghty
| University of Vermont | Doctorate Degree |
| The Carroll School | Masters Business Admin |
| Union College (New York) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Commercial Services |
- Stock Market
- Insiders
- Deborah Geraghty
